Prostate cancer gene 3 (Progensa PCA3) assay in the diagnosis of prostate cancer: horizon scanning technology briefing
NHSC
Record Status
This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database.
Citation
NHSC. Prostate cancer gene 3 (Progensa PCA3) assay in the diagnosis of prostate cancer: horizon scanning technology briefing. Birmingham: National Horizon Scanning Centre (NHSC). 2006
Authors' objectives
This study examines the use of prostate cancer gene 3 (Progensa PCA3) assay in the diagnosis of prostate cancer.
Department of Public Health and Epidemiology, The University of Birmingham, Edgbaston, Birmingham B15 2TT, UNITED KINGDOM, Tel: +44 121 414 7831, Fax: +44 121 2269 Email: c.packer@bham.ac.uk